Andrew Witty, UnitedHealth CEO, said the move will remove an excuse other players use to blame Optum Rx for high drug costs.
Hosted on MSN2h
Insurance Company Where CEO Was Assassinated Jacking Up Cost of Cancer Drugs by "Thousands of Percent," Government FindsUnitedHealthcare's legal drug dealing arm is, according to the government, massively marking up the cost of life-saving ...
Shares of insurers and pharmacy benefit manager (PBM) companies such as Centene, Elevance Health, Humana and CVS Health are ...
"While this information is theoretically available to the public, institutional owners' holdings are challenging to identify ...
Agency commissioners voted unanimously on Tuesday to publish the report, which makes similar allegations against the ...
Click in for more news from The Hill{beacon} Health Care Health Care   The Big Story Congress missed a chance at PBM reforms.
A new report by the Federal Trade Commission says pharmacy benefit management companies are driving up your out-of-pocket costs for prescription drugs.
UnitedHealth Group has reported quarterly profits of $5.5 billion after tax in its first earnings release since the killing ...
Shares of UnitedHealth Group Inc. were took a deep dive Thursday, after the healthcare giant missed quarterly revenue expectations for the first time in more than four years. And while the company ...
The Arkansas Pharmacists Association and Attorney General Tim Griffin held a press conference at 10:30 a.m. Thursday ...
A new FTC report blames Pharmacy Benefit Managers for marking up specialty drug prices, profiting $7.3 billion from cancer and HIV treatments between 2017-2022.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback